Naegleria infection medical therapy

Revision as of 19:11, 17 December 2012 by Kalsang Dolma (talk | contribs)
Jump to navigation Jump to search

Naegleria Infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Naegleria Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Naegleria infection medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Naegleria infection medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Naegleria infection medical therapy

CDC on Naegleria infection medical therapy

Naegleria infection medical therapy in the news

Blogs on Naegleria infection medical therapy

Directions to Hospitals Treating Naegleria infection

Risk calculators and risk factors for Naegleria infection medical therapy

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Several drugs are effective against Naegleria fowleri in the laboratory. However, their effectiveness is unclear since almost all infections have been fatal, even when people were treated. Amphotericin B has been successfully used in some cases to treat PAM caused by Naegleria fowleri.

References

Template:WH Template:WS